(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-13 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 802343
| Date | Daily Closing Price | Open | High | Low | Volume |
| 13 Fri Dec 2024 | 3.48 | 3.54 | 3.58 | 3.44 | 0.705 times |
| 12 Thu Dec 2024 | 3.56 | 3.64 | 3.75 | 3.56 | 0.824 times |
| 11 Wed Dec 2024 | 3.64 | 3.76 | 3.78 | 3.63 | 0.592 times |
| 10 Tue Dec 2024 | 3.76 | 3.71 | 3.79 | 3.66 | 0.881 times |
| 09 Mon Dec 2024 | 3.67 | 3.69 | 3.73 | 3.65 | 0.375 times |
| 26 Tue Nov 2024 | 3.41 | 3.42 | 3.47 | 3.39 | 0.758 times |
| 26 Tue Nov 2024 | 3.41 | 3.42 | 3.47 | 3.39 | 0.758 times |
| 25 Mon Nov 2024 | 3.42 | 3.52 | 3.58 | 3.41 | 2.986 times |
| 22 Fri Nov 2024 | 3.51 | 3.47 | 3.53 | 3.45 | 0.894 times |
| 21 Thu Nov 2024 | 3.46 | 3.44 | 3.56 | 3.43 | 1.15 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 3.5, but if it comes above 3.5, then a intra day buy could be more profitable.
If you take a sell trade below 3.5, then use 3.5 as stoploss and 3.3 as target. However if you take a buy trade in stock , then use 3.5 as stoploss and 3.58 as target.
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 3.30 |
| Downside Target | 3.39 |
| Upside Target | 3.58 |
| Upside Target | 3.79 |
| Upside Target | 3.84 |
| Upside Target | 3.95 |
| Upside Target | 3.99 |
| Upside Target | 4.35 |
| Upside Target | 4.73 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 3.35 |
| Downside Intraday Target | 3.22 |
| Upside Intraday Target | 3.7 |
| Upside Intraday Target | 3.92 |
| Upside Intraday Target | 3.57 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 13 Fri Dec 2024 | 3.48 | 3.69 | 3.79 | 3.44 | 4.453 times |
| 26 Tue Nov 2024 | 3.41 | 3.42 | 3.47 | 3.39 | 0.203 times |
| 26 Tue Nov 2024 | 3.41 | 3.52 | 3.58 | 3.39 | 0.708 times |
| 22 Fri Nov 2024 | 3.51 | 3.64 | 3.68 | 3.42 | 0.817 times |
| 15 Fri Nov 2024 | 3.64 | 3.75 | 3.84 | 3.42 | 1.016 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 13 Fri Dec 2024 | 3.48 | 3.69 | 3.79 | 3.44 | 0.145 times |
| 26 Tue Nov 2024 | 3.41 | 3.85 | 3.99 | 3.39 | 0.997 times |
| 31 Thu Oct 2024 | 3.85 | 3.81 | 4.35 | 3.65 | 0.552 times |
| 30 Mon Sep 2024 | 3.85 | 3.89 | 4.73 | 3.79 | 1.599 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term but the buy signal is initial and weak.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.5 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term but the buy signal is initial and weak.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.5 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.